The store will not work correctly when cookies are disabled.
rac-3-amino-4-(furan-2-yl)-8-methyl-5,6,7,8-tetrahydrothieno[2,3-b]quinoline-2-carboxamide
ID: ALA1092819
PubChem CID: 46884286
Max Phase: Preclinical
Molecular Formula: C17H17N3O2S
Molecular Weight: 327.41
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CC1CCCc2c1nc1sc(C(N)=O)c(N)c1c2-c1ccco1
Standard InChI: InChI=1S/C17H17N3O2S/c1-8-4-2-5-9-11(10-6-3-7-22-10)12-13(18)15(16(19)21)23-17(12)20-14(8)9/h3,6-8H,2,4-5,18H2,1H3,(H2,19,21)
Standard InChI Key: XVGQABLVENFIIP-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 26 0 0 0 0 0 0 0 0999 V2000
7.8980 -10.7790 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.9002 -9.1277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6138 -9.5381 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6112 -10.3700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4016 -10.6295 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
9.8927 -9.9580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4057 -9.2836 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6631 -8.4998 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.7177 -9.9605 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1280 -10.6762 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.1323 -9.2473 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.8997 -8.3027 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5616 -7.8175 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3062 -7.0330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4812 -7.0335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2268 -7.8183 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.1849 -10.3648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1887 -9.5393 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4795 -9.1255 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7621 -9.5328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7583 -10.3583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4720 -10.7766 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4694 -11.6016 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9 11 1 0
3 2 2 0
2 12 1 0
12 13 2 0
2 18 1 0
4 5 1 0
5 6 1 0
6 7 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 12 1 0
17 18 2 0
7 3 1 0
3 4 1 0
7 8 1 0
17 1 1 0
6 9 1 0
1 4 2 0
17 22 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
9 10 2 0
22 23 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 327.41 | Molecular Weight (Monoisotopic): 327.1041 | AlogP: 3.68 | #Rotatable Bonds: 2 |
Polar Surface Area: 95.14 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 3.38 | CX LogD: 3.38 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.75 | Np Likeness Score: -1.11 |
References
1. Lockman JW, Reeder MD, Suzuki K, Ostanin K, Hoff R, Bhoite L, Austin H, Baichwal V, Adam Willardsen J.. (2010) Inhibition of eEF2-K by thieno[2,3-b]pyridine analogues., 20 (7): [PMID:20189382] [10.1016/j.bmcl.2010.02.005] |